Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 3
2002 1
2003 2
2004 1
2006 1
2007 1
2010 2
2015 3
2016 2
2017 1
2018 2
2019 1
2020 1
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses.
Fiedler-Kelly J, Passarell J, Ludwig E, Levi M, Cohen-Barak O. Fiedler-Kelly J, et al. Among authors: cohen barak o. Headache. 2020 Jul;60(7):1376-1391. doi: 10.1111/head.13845. Epub 2020 May 23. Headache. 2020. PMID: 32445498 Free PMC article. Clinical Trial.
Predicting phenotype from genotype: normal pigmentation.
Valenzuela RK, Henderson MS, Walsh MH, Garrison NA, Kelch JT, Cohen-Barak O, Erickson DT, John Meaney F, Bruce Walsh J, Cheng KC, Ito S, Wakamatsu K, Frudakis T, Thomas M, Brilliant MH. Valenzuela RK, et al. Among authors: cohen barak o. J Forensic Sci. 2010 Mar 1;55(2):315-22. doi: 10.1111/j.1556-4029.2009.01317.x. Epub 2010 Feb 11. J Forensic Sci. 2010. PMID: 20158590 Free PMC article.
A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe.
Cherniakov I, Cohen-Barak O, Tiver R, Gillespie M, Kessler Y, Gutierrez M, Rasamoelisolo M, Li S, Shen H, Hallak H, Loupe PS, Smith M, Rabinovich-Guilatt L, Spiegelstein O. Cherniakov I, et al. Among authors: cohen barak o. Clin Pharmacol Drug Dev. 2021 Sep;10(9):1018-1027. doi: 10.1002/cpdd.902. Epub 2021 Jan 7. Clin Pharmacol Drug Dev. 2021. PMID: 33411992 Free PMC article. Clinical Trial.
Sox6 regulation of cardiac myocyte development.
Cohen-Barak O, Yi Z, Hagiwara N, Monzen K, Komuro I, Brilliant MH. Cohen-Barak O, et al. Nucleic Acids Res. 2003 Oct 15;31(20):5941-8. doi: 10.1093/nar/gkg807. Nucleic Acids Res. 2003. PMID: 14530442 Free PMC article.
Dose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic modeling and simulation approach.
Cohen-Barak O, Radivojevic A, Jones A, Fiedler-Kelly J, Gillespie M, Brennan M, Gutman D, Rasamoelisolo M, Hallak H, Loupe P, Kessler Y, Ning X, Levi M, Ahn AH, Rabinovich-Guilatt L. Cohen-Barak O, et al. Cephalalgia. 2021 Sep;41(10):1065-1074. doi: 10.1177/03331024211007789. Epub 2021 May 17. Cephalalgia. 2021. PMID: 34000848 Clinical Trial.
Pharmacokinetics, metabolism and safety of deuterated L-DOPA (SD-1077)/carbidopa compared to L-DOPA/carbidopa following single oral dose administration in healthy subjects.
Schneider F, Erisson L, Beygi H, Bradbury M, Cohen-Barak O, Grachev ID, Guzy S, Loupe PS, Levi M, McDonald M, Savola JM, Papapetropoulos S, Tracewell WG, Velinova M, Spiegelstein O. Schneider F, et al. Among authors: cohen barak o. Br J Clin Pharmacol. 2018 Oct;84(10):2422-2432. doi: 10.1111/bcp.13702. Epub 2018 Aug 9. Br J Clin Pharmacol. 2018. PMID: 29959802 Free PMC article. Clinical Trial.
Sox6 directly silences epsilon globin expression in definitive erythropoiesis.
Yi Z, Cohen-Barak O, Hagiwara N, Kingsley PD, Fuchs DA, Erickson DT, Epner EM, Palis J, Brilliant MH. Yi Z, et al. Among authors: cohen barak o. PLoS Genet. 2006 Feb;2(2):e14. doi: 10.1371/journal.pgen.0020014. Epub 2006 Feb 3. PLoS Genet. 2006. PMID: 16462943 Free PMC article.
23 results